Hepatitis B — United States

A birth dose since 1991, and since 2022 a recommendation that every adult under 60 be vaccinated.

Illustration: Hepatitis B — United States

The legal framework

The United States introduced universal infant vaccination with a birth dose in 1991, and has one of the longer-running programmes. Two recent changes matter for adults: since 2022 vaccination is recommended for all adults aged 19 to 59 regardless of risk factors, and national guidance now advises that every adult be screened for hepatitis B at least once in their life.

Key points

Birth doseWithin 24 hours of birth, since 1991
Adult vaccinationRecommended for everyone aged 19 to 59 since 2022, without needing a risk factor
Adult screeningRecommended at least once in a lifetime for all adults
Antenatal screeningUniversal, with repeat testing where risk is ongoing
Babies of carriersVaccine and immunoglobulin within 12 hours of birth
CoverageInsurance must cover recommended vaccines without cost sharing
Higher prevalence groupsPeople born in Asia, Africa and parts of eastern Europe

In practice

Cost and coverage

Recommended vaccines are covered without cost sharing by most insurance; free programmes exist for uninsured children.

Recent changes

The 2022 move to universal adult vaccination and the recommendation of once-in-a-lifetime adult screening were both intended to reach the large number of undiagnosed carriers.

Where to go

Worth knowing

The universal adult recommendation removed the need to disclose a risk factor in order to be vaccinated. You can simply ask for it.

Official sources and links

← All countries Hepatitis B →

Page checked in September 2026. The instruments cited can change: if in doubt, confirm with the official source given.

Locate this page in the site map

A question, a correction, a suggestion? Write to us.